GeoVax Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines

NEXT STORY
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen® for Vascular Repair
PREV STORY
Emerald Bioscience Appoints Biotech Veteran Dr. Margaret Dalesandro to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

HUTCHMED Initiates ESLIM-01, a Phase III Trial of HMPL-523 in Patients with Immune Thrombocytopenia in China

author_avatar
NASDAQ Market News

Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer

Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination ...

author_avatar
NASDAQ Market News

Novartis data highlight efficacy of Piqray® in HR+/HER2- metastatic breast cancer with a PIK3CA driver mutation immediately post-CDK4/6i

author_avatar
NASDAQ Market News